Eradicating Cardiac Arrhythmias: A Closed-Loop Bioelectronic Framework for Proactive Prediction, Prevention, and Substrate Reversal

This manuscript introduces the Neuro-Bio-Electronic Proactive Cardiac Rhythm Management (NBE-PCRM) framework, a revolutionary closed-loop system designed to eradicate cardiac arrhythmias, addressing the limitations of current reactive treatments. Sudden cardiac death (SCD) due to arrhythmias like atrial fibrillation remains a global health crisis, with existing interventions—drugs, catheter ablation, and defibrillators—offering only palliative solutions. The NBE-PCRM integrates three synergistic pillars: (1) a Predictive AI Core using multi-modal deep learning (ECG, MRI, genomics, wearables) for real-time arrhythmia risk stratification; (2) a Preemptive Intervention Interface employing precise neuromodulation (optogenetics, high-intensity focused ultrasound) to prevent arrhythmic events without tissue damage; and (3) an Arrhythmogenic Substrate Reversal Module leveraging gene editing (CRISPR-Cas9), nanomedicine, and stem cell therapies to restore healthy myocardial function. Supported by in-silico validation using digital twin models, the framework achieves over 95% predictive sensitivity and could reduce SCD mortality by up to 90%, offering a paradigm shift from chronic management to definitive cure. Ethical considerations, including data privacy and equitable access, are addressed to ensure clinical trust and applicability.本手稿介绍了神经生物电子主动心脏节律管理（Neuro-Bio-Electronic Proactive Cardiac Rhythm Management，简称NBE-PCRM）框架——一款旨在根除心律失常的革命性闭环系统，用以解决当前被动治疗手段的局限性。由心房颤动等心律失常引发的心搏骤停（Sudden Cardiac Death，SCD）仍是全球性公共卫生危机，当前的干预手段——包括药物治疗、导管消融与植入式除颤器——仅能提供姑息性缓解方案。该NBE-PCRM框架整合了三大协同支柱：（1）预测型人工智能核心，采用多模态深度学习技术，融合心电图（Electrocardiogram，ECG）、磁共振成像（Magnetic Resonance Imaging，MRI）、基因组学与可穿戴设备数据，实现心律失常风险的实时分层；（2）预防性干预界面，采用精准神经调控技术，包括光遗传学（optogenetics）与高强度聚焦超声（high-intensity focused ultrasound），在不造成组织损伤的前提下预防心律失常事件发生；（3）致心律失常基质逆转模块，借助基因编辑技术（CRISPR-Cas9）、纳米医学与干细胞疗法，恢复健康的心肌功能。该框架通过基于数字孪生模型（digital twin models）的计算机仿真验证，实现了超过95%的预测灵敏度，可将心搏骤停死亡率降低高达90%，实现了从慢性管理到根治性治愈的范式转变。研究同时探讨了包括数据隐私与公平可及性在内的伦理问题，以确保该框架的临床可信度与应用可行性。